Advertisement

Journal of Biomedical Science

, Volume 10, Issue 3, pp 328–336 | Cite as

Glass needle-mediated microinjection of macromolecules and transgenes into primary human mesenchymal stem cells

  • Tamara V. Tsulaia
  • Nicole L. Prokopishyn
  • Aqing Yao
  • N. D. Victor Carsrud
  • M. Clara Carou
  • David B. Brown
  • Brian R. Davis
  • Judith Yannariello-Brown
Original Paper

Abstract

Human mesenchymal stem cells (hMSCs) are multipotent cells that can differentiate into various tissue types, including bone, cartilage, tendon, adipocytes, and marrow stroma, making them potentially useful for human cell and gene therapies. Our objective was to demonstrate the utility of glass needle-mediated microinjection as a method to deliver macromolecules (e.g. dextrans, DNA) to hMSCs for cell and molecular biological studies. hMSCs were isolated and cultured using a specific fetal bovine serum, prescreened for its ability to promote cell adherence, proliferation, and osteogenic differentiation. Successful delivery of Oregon Green-dextran via intranuclear microinjection was achieved, yielding a postinjection viability of 76 ± 13%. Excellent short-term gene expression (63 ± 11%) was achieved following microinjection of GFP-containing vectors into hMSCs. Higher efficiencies of short-term gene expression (∼5-fold) were observed when injecting supercoiled DNA, pYA721, as compared with the same DNA construct in a linearized form, YA721. Approximately 0.05% of hMSCs injected with pYA721 containing both the GFP and neomycin resistance genes formed GFP-positive, drug-resistant colonies that survived >120 days. Injection of linearized YA721 resulted in 3.6% of injected hMSC forming drug-resistant colonies, none of which expressed GFP that survived 60–120 days. These studies demonstrate that glass needle-mediated microinjection can be used as a method of delivering macromolecules to hMSCs and may prove to be a useful technique for molecular and cell biological mechanistic studies and future genetic modification of hMSCs.

Key Words

Gene delivery methods Gene therapy Mesenchymal stem cells Microinjection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alberts A, Montminy M, Shenolikar S, Feramisco J. Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol 14:4398–4407;1994.Google Scholar
  2. 2.
    Ansorge W. Improved system for capillary microinjection into living cells. Exp Cell Res 140:31–37;1982.Google Scholar
  3. 3.
    Ansorge W, Pepperkok R. Performance of an automated system for capillary microinjection into living cells. J Biochem Biophys Methods 16:283–292;1988.Google Scholar
  4. 4.
    Ashton BA, Abdullah F, Cave J, Williamson M, Sykes BC, Couch M, Poser JW. Characterization of cells with high alkaline phosphatase activity derived from human bone and marrow: Preliminary assessment of their osteogenicity. Bone 6:313–319;1985.Google Scholar
  5. 5.
    Bruder SP, Horowitz MC, Haynesworth SE. Monoclonal antibodies selective for human osteogenic cell surface antigens. Bone 21:225–235;1997.Google Scholar
  6. 6.
    Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following criopreservation. J Cell Biochem 64:278–294;1997.Google Scholar
  7. 7.
    Caplan AI. Mesenchymal stem cells. J Orthop Res 9:641–650;1991.Google Scholar
  8. 8.
    Caplan AI. Mesenchymal stem cells and gene therapy. Clin Orthop Res (379 suppl):S67–S70;2000.Google Scholar
  9. 9.
    Capecchi M. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22:479–488;1980.Google Scholar
  10. 10.
    Chung JH, Bell AC, Felsenfeld G. Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci USA 94:575–580;1997.Google Scholar
  11. 11.
    Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 6:1574–1583;1999.Google Scholar
  12. 12.
    Colosimo A, Gonecz KK, Novelli G, Dallapiccola B, Gruenert DC. Targeted correction of defective selectable marker gene in human epithelial cells by small DNA fragments. Mol Ther 3:178–185;2001.Google Scholar
  13. 13.
    Davis BR, Brown DB, Prokopishyn NL, Yannariello-Brown J. Micro-injection-mediated hematopoietic stem cell gene therapy. Curr Opin Mol Ther 2:412–419;2000.Google Scholar
  14. 14.
    Davis BR, Yannariello-Brown J, Prokopishyn NL, Wang J, Smith M, Lou ZJ, Brown DB. Microinjection-mediated delivery of macromolecules and transgenes to primary human blood stem/progenitor cells. Blood 95:437–444;2000.Google Scholar
  15. 15.
    Ferrari G, Angelis GC, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528–1530;1998.Google Scholar
  16. 16.
    Flanagan WM, Wagner RW. Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol Cell Biochem 172:213–225;1997.Google Scholar
  17. 17.
    Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson F, Hall FL. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-β1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Hum Gene Ther 8:1385–1394;1997.Google Scholar
  18. 18.
    Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263–272;1987.Google Scholar
  19. 19.
    Golde D, Hocking W, Quan S, Sparkes R, Gale R. Origin of the human bone marrow fibroblasts. Br J Hematol 44:183–187;1980.Google Scholar
  20. 20.
    Goncz KK, Gruenert DC. Site-directed alteration of genomic DNA by small-fragment homologous replacement. Methods Mol Biol 133:85–99;2000.Google Scholar
  21. 21.
    Gruenert DC. Opportunities and challenges in targeting genes for therapy. Gene Ther 6:1347–1348;1999.Google Scholar
  22. 22.
    Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 13:81–88;1992.Google Scholar
  23. 23.
    Haynesworth SE, Baber MA, Caplan AI. Characterization of the unique mesenchymal stem cell phenotype in vitro. Trans Orthop Res Soc 29:641–649;1995.Google Scholar
  24. 24.
    Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Kneel M, Busman M, Orchard P, Marx JC, Pyeritz RE, Brener KM. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313;1999.Google Scholar
  25. 25.
    Hyland JK, Rogers CM, Scolnick EM, Stein RB, Ellis R, Baserga R. Microinjectedras family oncogenes stimulate DNA synthesis in quiescent mammalian cells. Virology 141:333–336;1985.Google Scholar
  26. 26.
    Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295–312;1997.Google Scholar
  27. 27.
    Johnstone B, Yoo JU, Barry F. In vitro chondrogenesis of bone marrow-derived mesenchymal cells. Exp Cell Res 238:265–272;1998.Google Scholar
  28. 28.
    Kmiec EB, Ye S, Peng L. Targeted gene repair in mammalian cells using chimeric oligonucleotides. Genet Eng 22:23–31;2000.Google Scholar
  29. 29.
    Lajtha LG. Tissues and stem cells. Biomed Pharmacother 36:231–233;1982.Google Scholar
  30. 30.
    Lamb NJC, Fernandez A. Microinjection of antibodies into mammalian cells. Methods Enzymol 283:72–83;1997.Google Scholar
  31. 31.
    Lazarus H, Haynesworth SE, Gerson S, Rosenthal N, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implication for therapeutic use. Bone Marrow Transplant 16:557–564;1995.Google Scholar
  32. 32.
    Legerski RJ, Brown DB, Peterson CA, Robberson DL. Transient complementation ofXeroderma pigmentosum cells by microinjection of poly (A)+RNA. Proc Natl Acad Sci USA 81:5676–5679;1984.Google Scholar
  33. 33.
    Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 32:602–611;1996.Google Scholar
  34. 34.
    Liu L, Rice MC, Kmiec EB. In vivo gene repair of point and frame shift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res 29:4238–4250;2001.Google Scholar
  35. 35.
    Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415–428;1998.Google Scholar
  36. 36.
    Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57–66;1998.Google Scholar
  37. 37.
    Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hematopoietic microenvironment. Eur J Hematol 49:225–233;1992.Google Scholar
  38. 38.
    Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239–4242;1990.Google Scholar
  39. 39.
    Miskimins WK, Brown DB. Analysis of cis-acting promoter elements using microinjected synthetic oligonucleotides. Exp Cell Res 191:328–331;1990.Google Scholar
  40. 40.
    Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang CL, Majumdar M, Chopra R, Barry F, Murphy M, Thiede M, Junker U, Rigg R, Forestell S, Bohnlein E, Storb R, Sanmaier BM. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop Relat Res (379 suppl):S71–S90;2000.Google Scholar
  41. 41.
    Nakahara H, Goldberg V, Caplan AI. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9:465–478;1991.Google Scholar
  42. 42.
    Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844–2853;1993.Google Scholar
  43. 43.
    Pepperkok R, Schneider C, Philipson L, Ansorge W. Single cell assay with an automated capillary microinjection system. Exp Cell Res 178:369–376;1988.Google Scholar
  44. 44.
    Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147;1999.Google Scholar
  45. 45.
    Pittenger MF, Mosca JD, Mcintosh KR. Human mesenchymal stem cells: Progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol 251:3–11;2000.Google Scholar
  46. 46.
    Pittenger MF, Mackay AM, Beck SC. Human mesenchymal stem cells can be directed into chondrocytes, adipocytes and osteocytes (abstract 1772). Mol Biol Cell 7:305;1996.Google Scholar
  47. 47.
    Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276:71–75;1997.Google Scholar
  48. 48.
    Recillas-Targa F, Bell AC, Felsenfeld G. Positional enhancer-blocking activity of the chicken beta-globin insulator in transiently transfected cells. Proc Natl Acad Sci USA 96:14354–14357;1999.Google Scholar
  49. 49.
    Rice MC, Czymmek K, Kmiec EB. The potential of nucleic acid repair in functional genomics. Nat Biotechnol 19:321–326;2001.Google Scholar
  50. 50.
    Rodan G, Martin TJ. Therapeutic approaches to bone diseases. Tissue engineers build new bone. Science 289:1498–1500, 1508–1514;2000.Google Scholar
  51. 51.
    Somia N, Verma IM. Gene therapy: Trials and tribulations. Nat Rev Genet 1:91–99;2001.Google Scholar
  52. 52.
    Stacey D. Microinjection of mRNA and other macromolecules into living cells. Methods Enzymol 79:76–88;1981.Google Scholar
  53. 53.
    Stacey DW, Hsiang-Fu K. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature 310:508–511;1984.Google Scholar
  54. 54.
    Tezuka K, Yasuda M, Watanabe N, Morimura N, Kuroda K, Miyatani S, Hozumi N. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 17:231–239;2002.Google Scholar
  55. 55.
    Verma IM, Somia N. Gene therapy — Promises, problems and prospects. Nature 389:239–242;1997.Google Scholar
  56. 56.
    Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW. Regulatory systems for use in gene transfer. Proc Natl Acad Sci USA 91:8180–8184;1994.Google Scholar

Copyright information

© National Science Council 2003

Authors and Affiliations

  • Tamara V. Tsulaia
    • 1
    • 3
    • 6
  • Nicole L. Prokopishyn
    • 4
  • Aqing Yao
    • 2
    • 3
  • N. D. Victor Carsrud
    • 1
    • 4
  • M. Clara Carou
    • 1
    • 3
  • David B. Brown
    • 1
    • 3
    • 4
  • Brian R. Davis
    • 2
    • 3
    • 4
  • Judith Yannariello-Brown
    • 1
    • 3
    • 4
    • 5
  1. 1.Department of Human Biological Chemistry and GeneticsUniversity of Texas Medical BranchGalveston
  2. 2.Department of Microbiology and ImmunologyUniversity of Texas Medical BranchGalveston
  3. 3.Department of Sealy Center for Oncology and HematologyUniversity of Texas Medical BranchGalveston
  4. 4.Gene-Cell, Inc.Houston
  5. 5.Tissue Transformation Technologies, Inc.EdisonUSA
  6. 6.Chrysalis Biotechnology, Inc.GalvestonUSA

Personalised recommendations